Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling - Top-Institutions - MDSpire

Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling

  • By

  • Feng-Xian Ni

  • Shao-Cong Ren

  • Jie Hu

  • Pei-Sheng Chen

  • Hui-Hui Chen

  • Dong-Hui Huang

  • Ze-Bo Jiang

  • June 23, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    UCSF Health – UCSF Medical Center
    UCSF Health – UCSF Medical Center

    San Francisco, California

    Key Differentiators

    • Pulmonology
    • Asthma Research

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Pulmonology
    • Asthma Research

  • #3

    University of Bergen
    University of Bergen

    Bergen, Norway

    Key Differentiators

    • Pulmonology

  • #4

    Haukeland University Hospital
    Haukeland University Hospital

    Bergen, Norway

    Key Differentiators

    • Pulmonology

  • #5

    Taiwan Childhood Environment and Allergic Diseases Cohort Study
    Taiwan Childhood Environment and Allergic Diseases Cohort Study

    Taipei, Taiwan

    Key Differentiators

    • Pediatric Pulmonology

Original Source(s)

Necroptosis in asthma: a critical driver of immune dysregulation and airway remodeling

  • by Feng-Xian Ni, Shao-Cong Ren, Jie Hu, Pei-Sheng Chen, Hui-Hui Chen, Dong-Hui Huang, Ze-Bo Jiang

  • June 23, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Relapsing allergic bronchopulmonary aspergillosis as a trigger for Kounis syndrome: a case report

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.